Jagsonpal Pharmaceuticals informs about un-audited financial results

13 Feb 2019 Evaluate

Pursuant to Regulation 33(3)(d) read with Regulation 47(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jagsonpal Pharmaceuticals has informed about submission of the Certified True Copies of publication of Standalone Un-Audited Financial Results for the Quarter ended 31st December, 2018, approved at the meeting of the Board of Directors of the company held on 13th February, 2019 at the registered office of the company. Further, the publication was made in one English and Hindi Newspaper of Business Standard respectively.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

640.20 48.55 (8.21%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.